As the effectiveness of antibiotics meant to fight the deadly superbug Clostridioides difficile, or C. diff, wanes, a research team at the University of Houston is seeing positive results of a new antibiotic on the scene—ibezapolstat—which is proving successful in fighting these infectious bacteria in clinical trials.
Go to Source
https://medicalxpress.com/rss-feed/